Home > List All Publishers > CBR Pharma Insights, LLC

CBR Pharma Insights, LLC

The mission of CBR Pharma Insights is to empower companies within the pharmaceutical industry to make the best business decisions possible through providing them with quality, innovative, strategic market research solutions.

CBR’s market research solutions are focused on being both proactive & reactive in identifying, evaluating, and assessing the key strategic R&D and commercial issues within the pharmaceutical industry.

List of reports from CBR Pharma Insights, LLC

Oncology Development Strategies – Considerable Commercial Potential but Specific Needs Must Be Addressed 1/1/2013 \| published by: CBR Pharma Insights, LLC ... drugs that get to Phase III proceeding to approval. There are a number of factors that will affect the likelihood of success in oncology drug development and these must be taken into consideration when designing ... \| more... Search inside this report	$3,900.00
The Digital Patient – A Snapshot of the Digital Landscape of Patients and Caregivers 11/1/2012 \| published by: CBR Pharma Insights, LLC ... patients and caregivers have pre-existing expectations of the digital experience. Digital enables brands to deliver highly targeted information in a variety of forms. It creates the setting for a brand experience versus a promotional moment. ... \| more... Search inside this report	$3,900.00
Biologics in the Emerging Markets – Ripe for Realization of the Commercial Potential – But Hurdles Still to Overcome 9/1/2012 \| published by: CBR Pharma Insights, LLC ... many less developed healthcare markets. However, the global biologics market is rapidly growing and was estimated to be worth over $130 billion in 2010. Of the emerging markets, the BRIC markets offer the greatest potential ... \| more... Search inside this report	$3,900.00
Emerging Pharmaceutical Technologies – Stem Cells 8/1/2012 \| published by: CBR Pharma Insights, LLC ... largely unproven at present. Even if companies are not interested in joining the first wave of stem cell therapy developers, they need to be monitoring this sector in order to understand future competitive threats. The ... \| more... Search inside this report	$3,900.00
Accountable Care Organizations – A Building Block for the Future of Health Care 8/1/2012 \| published by: CBR Pharma Insights, LLC ... is the Medicare Shared Savings Program, under which ACOs gradually share in the cost savings they achieve through providing coordinated and consistent care to groups of Medicare beneficiaries while meeting quality targets. The focus of ... \| more... Search inside this report	$3,900.00
Clinical Development and Trial Design – Developing a Coherent Approach from Beginning to End 6/1/2012 \| published by: CBR Pharma Insights, LLC ... streamlined process throughout. The clinical development plan ties together all aspects of product development, enabling an incorporated approach to the clinical and commercial rationale of product development. A variety of approaches should be adopted to ... \| more... Search inside this report	$3,900.00
Diversification in the Pharmaceutical Industry – Essential For Survival or an Unnecessary Distraction? 5/1/2012 \| published by: CBR Pharma Insights, LLC ... remains split on whether diversification or specialization is the key to building a successful business model in the face of these difficulties. On one hand some companies believe that diversification is necessary to survive and ... \| more... Search inside this report	$3,900.00
The Payer Landscape in the United States – The Pharmaceutical Industry Faces a Rapidly Changing Marketplace 3/1/2012 \| published by: CBR Pharma Insights, LLC ... 2010 providing changes for both. That said, private payers, such as regionals, nationals and blues plans, may take the brunt of the reform policies put in place. The health care reform legislation in 2010 was ... \| more... Search inside this report	$3,900.00
The Next Generation of Pharmaceutical Marketing Strategies – Understanding All of the Strategic Considerations Needed in the Age of Multiple Stakeholders 3/1/2012 \| published by: CBR Pharma Insights, LLC ... a period of great transformation. Lacking a crystal ball, the industry as a whole is navigating through unchartered waters. Multiple factors are driving the need for industry-wide change. One of the biggest contributors is the ... \| more... Search inside this report	$3,900.00
Pharmaceutical Pricing Strategies – Changing Approaches to Meet Challenging Times 3/1/2012 \| published by: CBR Pharma Insights, LLC ... discounts forced upon them and new drugs being subject to increasingly complex assessments in order to obtain the desired price. Novel pricing policies, such as value based pricing and external price referencing, are being employed ... \| more... Search inside this report	$3,900.00
Reformulation Strategies – New Technologies Extend Use Beyond Lifecycle Management 1/1/2012 \| published by: CBR Pharma Insights, LLC ... new technologies emerge compliment its position as a key lifecycle management strategy. Reformulation will continue to be a much used lifecycle management strategy, enabling companies to boost sales before patent expiry and in ideal cases ... \| more... Search inside this report	$3,900.00
Looking at Senior Long-term Care - Where Will the Market Go? P 12/1/2011 \| published by: CBR Pharma Insights, LLC ... Skilled Nursing. Memory Care facilities, for those with Alzheimer’s Disease or Dementia are often separate facilities, but may be part of a larger CCRC campus. Long-term care is becoming increasingly important as a market with ... \| more... Search inside this report	$3,900.00
The Impact of Generics on Pharmaceutical Growth Opportunities - A growing threat that offers future opportunities 10/1/2011 \| published by: CBR Pharma Insights, LLC ... this, pharma is experiencing a wave of blockbuster patent expiries, with almost $30 billion in US sales (at 2010 levels) exposed by the largest 10 drugs which are expected to experience generic competition for the ... \| more... Search inside this report	$3,900.00
Risk Evaluation and Mitigation Strategies - Adaptation in an Evolving System 10/1/2011 \| published by: CBR Pharma Insights, LLC ... (REMS) program in 2008. Products can be approved with a Medication Guide only REMS, a Communication Plan REMS - which incorporates a Medication Guide together with educational materials for providers or it can require Elements ... \| more... Search inside this report	$3,900.00
Accelerating Drugs to Market - In Search of Opportunity Along the Drug Development & Approval Pathway 9/1/2011 \| published by: CBR Pharma Insights, LLC ... gain competitive advantages and to start recouping development costs. From product concept to market, there are a number of potential areas of opportunity for accelerating a drug through to FDA approval. Many initiatives tie to ... \| more... Search inside this report	$3,900.00
Pharmaceutical Sales Force Effectiveness - Rethinking the Current Sales Model 8/1/2011 \| published by: CBR Pharma Insights, LLC ... to this mix Health Care Reform and the way a company develops, markets, and sells their products is impacted on some level. The next 5 - 10 years will be an exciting time to be ... \| more... Search inside this report	$3,900.00
Pharmaceutical Cliff Diving - Assessing the Key Challenges that will Re-Shape the Industry 7/1/2011 \| published by: CBR Pharma Insights, LLC ... big pharma, sales were flat to negative for most, but a number of companies found that their work to streamline and restructure were showing positive results, with Q1 profits up. The industry faces challenges from ... \| more...	$3,900.00
The Coming Age of Biosimilars - Regulatory Developments and Alliance Strategies Intensify Interest in a Developing Market 5/1/2011 \| published by: CBR Pharma Insights, LLC ... predicting it will grow to the multi-billion dollar level within five years, while others point to the limited impact of biosimilars in Europe to date to suggest that it will never be a major threat ... \| more...	$3,900.00
New Product Launch Strategies - Initiating Market Entry with Sound Strategies and Tactics 4/1/2011 \| published by: CBR Pharma Insights, LLC ... growth; however lost opportunities at the entry of a product to a market can necessitate re- launch and re-branding activities which can be costly and cumbersome. Additionally, these “Plan B” tactics are not always effective. ... \| more...	$3,900.00
The Impact of Economic Factors on the Pharmaceutical Industry - Where the Next Five Years Will Take Us 3/1/2011 \| published by: CBR Pharma Insights, LLC ... we’re currently in has brought a number of challenges for the pharmaceutical industry, such as loss of health coverage through unemployment, decreasing health benefits for those still employed, and a lessened ability to pay for ... \| more...	$3,900.00
Pharmaceutical and Biotech Licensing Strategies - Driving Revenue through Partnerships 1/1/2011 \| published by: CBR Pharma Insights, LLC ... one grounded in collaboration. Companies are no longer relying solely on their own internal R&D programs for innovation; they are looking outside of their four walls. Some have labeled this ‘search and development’. There are ... \| more...	$3,900.00
Managed Care and the Pharmaceutical Industry - Top Issues, Health Care Reform, and the Inter-linkages Bringing them Together 12/1/2010 \| published by: CBR Pharma Insights, LLC ... of their brand-name drugs. Common ground between the two industries can be difficult to find. Shared goals do exist, though. Both the managed care industry and the pharmaceutical industry have a stake in how prescription ... \| more...	$3,900.00
Personalized Medicine - Opening Doors and Overcoming Challenges 11/1/2010 \| published by: CBR Pharma Insights, LLC ... has begun to change as more personalized medicines have been developed outside of the oncology field. The spread of personalized medicine to other fields has increased the challenge of physician uptake, with many GPs not ... \| more...	$3,900.00
The Perception of the Pharmaceutical Industry - What the Web is Saying about Health Care Reform, Safety, and Drug Costs 10/1/2010 \| published by: CBR Pharma Insights, LLC ... with filling a prescription. Even though the industry will be contributing approximately $80 billion in fees and rebates towards the recent US health care reform legislation, the consumers’ perception is that they have actually contributed ... \| more...	$3,900.00
The Aging Population - How and Where to Succeed with the Over 50 Crowd 9/1/2010 \| published by: CBR Pharma Insights, LLC ... total population. By 2050, this figure is estimated to grow to 20% - increasing the burden placed on society. Today’s Seniors are happy, active, and living in the communities of their choice. This independence, which ... \| more...	$3,900.00

< prev 1 2 next >

CBR Pharma Insights, LLC

List of reports from CBR Pharma Insights, LLC

Research assistance

Join Alert Me now!